Total Payments
$5,160
2024 Payments
$1,211
Companies
22
Transactions
98
Medicare Patients
2,427
Medicare Billing
$264,561
Payment Breakdown by Category
Food & Beverage$3,275 (63.5%)
Travel$1,843 (35.7%)
Education$42.32 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,275 | 91 | 63.5% |
| Travel and Lodging | $1,843 | 5 | 35.7% |
| Education | $42.32 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,160 | 16 | $0 (2024) |
| ABBVIE INC. | $829.56 | 24 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $470.29 | 4 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $361.35 | 3 | $0 (2024) |
| Madrigal Pharmaceuticals | $265.78 | 3 | $0 (2024) |
| Gilead Sciences, Inc. | $176.35 | 13 | $0 (2024) |
| PFIZER INC. | $135.35 | 4 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $123.12 | 1 | $0 (2022) |
| Lilly USA, LLC | $100.15 | 4 | $0 (2024) |
| Celgene Corporation | $85.31 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,211 | 39 | Madrigal Pharmaceuticals ($265.78) |
| 2023 | $770.66 | 20 | ABBVIE INC. ($483.30) |
| 2022 | $594.29 | 11 | Janssen Scientific Affairs, LLC ($237.05) |
| 2021 | $149.62 | 5 | BOSTON SCIENTIFIC CORPORATION ($120.49) |
| 2020 | $1,291 | 8 | Boston Scientific Corporation ($1,155) |
| 2018 | $1,033 | 7 | BOSTON SCIENTIFIC CORPORATION ($854.76) |
| 2017 | $109.68 | 8 | Gilead Sciences Inc ($109.68) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $30.16 | General |
| Category: General - Hemostasis_ENDO | ||||||
| 12/10/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $148.88 | General |
| Category: LIVER DISEASE | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $97.68 | General |
| Category: LIVER DISEASE | ||||||
| 11/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: LIVER DISEASE | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Immunology | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $119.13 | General |
| Category: Neuroscience | ||||||
| 10/01/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $121.14 | General |
| Category: Neuroscience | ||||||
| 09/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.42 | General |
| Category: Neuroscience | ||||||
| 08/28/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $79.81 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 08/20/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $27.89 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/13/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 07/30/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Rare Disease | ||||||
| 07/24/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Immunology | ||||||
| 07/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.07 | General |
| Category: Neuroscience | ||||||
| 06/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/11/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 540 | 603 | $723,373 | $66,868 |
| 2022 | 18 | 558 | 602 | $603,196 | $60,741 |
| 2021 | 20 | 714 | 760 | $710,965 | $72,962 |
| 2020 | 14 | 615 | 668 | $686,042 | $63,989 |
Total Patients
2,427
Total Services
2,633
Medicare Billing
$264,561
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 91 | 91 | $125,762 | $11,316 | 9.0% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 25 | 31 | $96,348 | $9,426 | 9.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 93 | 108 | $99,684 | $8,274 | 8.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 32 | 32 | $52,928 | $6,314 | 11.9% |
| 43275 | Removal of stent from pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 17 | 17 | $42,874 | $4,723 | 11.0% |
| 43238 | Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | Facility | 2023 | 23 | 23 | $34,937 | $3,880 | 11.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2023 | 22 | 22 | $26,114 | $3,875 | 14.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2023 | 19 | 19 | $22,553 | $3,252 | 14.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 38 | $15,922 | $2,675 | 16.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $12,411 | $2,307 | 18.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $19,233 | $2,287 | 11.9% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 29 | 45 | $121,095 | $2,165 | 1.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 13 | 14 | $16,618 | $1,794 | 10.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $10,890 | $1,530 | 14.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $6,800 | $1,105 | 16.3% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 32 | 50 | $4,350 | $883.00 | 20.3% |
| 43450 | Dilation of esophagus | Office | 2023 | 19 | 20 | $9,420 | $551.54 | 5.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $5,434 | $510.32 | 9.4% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 21 | 24 | $67,800 | $8,454 | 12.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 74 | 74 | $92,944 | $7,450 | 8.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 35 | 35 | $52,640 | $6,840 | 13.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 77 | 85 | $71,315 | $6,614 | 9.3% |
| 43238 | Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | Facility | 2022 | 32 | 32 | $44,192 | $5,596 | 12.7% |
| 43275 | Removal of stent from pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 19 | 20 | $45,860 | $4,974 | 10.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2022 | 23 | 23 | $24,817 | $3,970 | 16.0% |
About Khaled Issa
Khaled Issa is a Gastroenterology healthcare provider based in Westlake, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801818646.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Khaled Issa has received a total of $5,160 in payments from pharmaceutical and medical device companies, with $1,211 received in 2024. These payments were reported across 98 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,275).
As a Medicare-enrolled provider, Issa has provided services to 2,427 Medicare beneficiaries, totaling 2,633 services with total Medicare billing of $264,561. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Westlake, OH
- Active Since 07/24/2006
- Last Updated 08/12/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1801818646
Products in Payments
- SPYGLASS (Device) $886.81
- AXIOS (Device) $610.84
- STELARA (Biological) $507.74
- ZEPOSIA (Drug) $446.66
- SKYRIZI (Biological) $437.60
- RINVOQ (Biological) $369.62
- GENERAL - BILIARY DEVICES (Device) $280.24
- REZDIFFRA (Drug) $246.56
- GENERAL BIOPSY (Device) $224.61
- OCALIVA (Drug) $123.12
- Epclusa (Drug) $96.63
- DUPIXENT (Biological) $88.89
- VELSIPITY (Drug) $82.91
- OMVOH (Drug) $74.05
- CAIMAN VESSEL SEALERS (Device) $69.73
- XELJANZ (Drug) $52.44
- EXALT (Device) $50.10
- ENTYVIO (Biological) $47.40
- RESOLUTION CLIP (Device) $45.58
- CIMZIA (Drug) $29.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Westlake
Mohamed Naem, Md, MD
Gastroenterology — Payments: $502,724
Gastroenterology $502,724
Mousab Tabbaa, Md, MD
Gastroenterology — Payments: $76,246
Gastroenterology $76,246
Preeti Jhawar, Do, DO
Gastroenterology — Payments: $32,669
Gastroenterology $32,669
Rinjal Brahmbhatt, Md, MD
Gastroenterology — Payments: $24,119
Gastroenterology $24,119
Peter Greenwalt, Md, MD
Gastroenterology — Payments: $10,592
Gastroenterology $10,592
Dr. Iqbal Ahmed, Md, MD
Gastroenterology — Payments: $9,547
Gastroenterology $9,547